Huapont Life Sciences Co Ltd (002004) — Cash Flow-to-Debt Ratio
Huapont Life Sciences Co Ltd (002004) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥635.17 Million could theoretically repay 0% of its total liabilities (CN¥13.15 Billion) in one year. See Huapont Life Sciences Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Huapont Life Sciences Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Huapont Life Sciences Co Ltd across 24 annual periods. Also explore net asset growth rate of Huapont Life Sciences Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Huapont Life Sciences Co Ltd. For market capitalisation and broader financial context, see 002004 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +49.6% |
| 2024 | 0.12x | CN¥1.63 Billion | CN¥13.98 Billion | ▲ +3.5% |
| 2023 | 0.11x | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -37.1% |
| 2022 | 0.18x | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +100.2% |
| 2021 | 0.09x | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -47.0% |
| 2020 | 0.17x | CN¥2.37 Billion | CN¥14.09 Billion | ▲ +8.3% |
| 2019 | 0.16x | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +12.4% |
| 2018 | 0.14x | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +269.3% |
| 2017 | 0.04x | CN¥591.40 Million | CN¥15.79 Billion | ▼ -1.1% |
| 2016 | 0.04x | CN¥511.90 Million | CN¥13.52 Billion | ▲ +2.8% |
| 2015 | 0.04x | CN¥342.45 Million | CN¥9.30 Billion | ▼ -36.7% |
| 2014 | 0.06x | CN¥455.96 Million | CN¥7.84 Billion | ▼ -39.5% |
| 2013 | 0.10x | CN¥349.51 Million | CN¥3.64 Billion | ▲ +10.6% |
| 2012 | 0.09x | CN¥257.75 Million | CN¥2.97 Billion | ▲ +3.1% |
| 2011 | 0.08x | CN¥135.23 Million | CN¥1.60 Billion | ▼ -65.9% |
| 2010 | 0.25x | CN¥79.84 Million | CN¥322.58 Million | ▼ -50.8% |
| 2009 | 0.50x | CN¥123.53 Million | CN¥245.68 Million | ▲ +43.8% |
| 2008 | 0.35x | CN¥113.76 Million | CN¥325.26 Million | ▲ +58.0% |
| 2007 | 0.22x | CN¥79.21 Million | CN¥357.78 Million | ▼ -18.9% |
| 2006 | 0.27x | CN¥66.10 Million | CN¥242.18 Million | ▼ -76.8% |
| 2005 | 1.18x | CN¥43.69 Million | CN¥37.17 Million | ▲ +32.2% |
| 2004 | 0.89x | CN¥70.60 Million | CN¥79.39 Million | ▲ +25.5% |
| 2003 | 0.71x | CN¥56.68 Million | CN¥79.99 Million | ▲ +101.6% |
| 2002 | 0.35x | CN¥36.88 Million | CN¥104.91 Million | — |